The long-term international safety experience of imiglucerase therapy for Gaucher disease

Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources

Gregory A. Grabowski · Annals of Internal Medicine · 1995 · 448 citations

Life Sciences, Biochemistry, Hematology +14

The Metabolism of Glucocerebrosides

Roscoe O. Brady, Julian N. Kanfer, David J. Shapiro · Journal of Biological Chemistry · 1965 · 278 citations · Full text

Life Sciences, Biochemistry, Carbohydrate Biochemistry +8

Immunosurveillance of Alglucerase Enzyme Therapy for Gaucher Patients: Induction of Humoral Tolerance in Seroconverted Patients After Repeat Administration

Mireille Rosenberg, Wytske Kingma, Mary Anne Fitzpatrick et al. · Blood · 1999 · 121 citations

Life Sciences, Immunology, Pharmacology +12

Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up

Robert L. Knobler, Jeffrey I. Greenstein, K. P. Johnson et al. · Journal of Interferon Research · 1993 · 109 citations

Life Sciences, Pharmacology, Pharmacotherapy +11

Long-term outcome of individuals with pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant epoetin: a follow-up report from the Research on Adverse Drug Events and Reports (RADAR) Project

Charles L. Bennett · Blood · 2005 · 101 citations · Full text

Medicine, Hematology, Pharmacology +7